title: [The hyperuricosuria in patients with high content of triglycerides: the combination of genetic and environmental factors and tactics of treatment].
abstract: The increasing of uric acid level (hyperuricosuria) is regularly detected in blood during the examination of patient with such cardiovascular diseases as arterial hypertension, atherosclerosis, diabetes mellitus, metabolic syndrome and obesity. The hyperiricosuria and hypertriglyceridemia are two independent risk factors, especially for arterial hypertension. The higher level of uric acid combined with hyper-lipoproteinemia (phenotypes) IIa and IIb was noted in 65% of patients. In males, hyperiricosuria was detected more often than in females. In groups with higher content of uric acid, the significant difference between median and quartiles was determined concerning the indicators of height, body mass, triglycerides concentration, beta-lipoprotein fractions content, pre beta-lipoprotein fractions content, apolipoprotein E in blood serum and apolipoprotein B=100 lipoproteins, but not both apolipoprotein C=III and apolipoprotein E in lipoproteins of high density. The increase of concentration of triglycerides and uric acid in blood is the outcome of disorder of metabolism of fat acids and nucleotides under surplus intake of substances with food. The fructose of sweet drinks can be considered as the source of fructose. The fructose is capable to increase the concentration of uric acid The catabolism of nucleotides is under regulatory impact of fructose: dicarboxylic derivatives can provoke increase of uric acid concentration. The treatment of patients with hyper-triglycerideimia, hyperiricosuria and hyperglycemia has to begin from decreasing of triglycerides concentration, dietotherapy and further if it is necessary, to apply the hypolipidemic therapy with fibrates.
authors.forename: T A
authors.initials: TA
authors.lastname: Rozhkova
authors.forename: V A
authors.initials: VA
authors.lastname: Ameliushkina
authors.forename: E B
authors.initials: EB
authors.lastname: Iarovaia
authors.forename: T I
authors.initials: TI
authors.lastname: Kotkina
authors.forename: P P
authors.initials: PP
authors.lastname: Malusheva
authors.forename: V N
authors.initials: VN
authors.lastname: Titov
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004777:Environment; D005632:Fructose / Q000378:metabolism*; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000473:pathology; D015228:Hypertriglyceridemia / Q000097:blood / Q000150:complications / Q000473:pathology; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood*; D014527:Uric Acid / Q000097:blood*
chemical_list: D008074:Lipoproteins; D014280:Triglycerides; D014527:Uric Acid; D005632:Fructose